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Abstract
Background: Inadequate identification and treatment of substance use (SU) and mental health (MH) disorders
hinders retention in HIV care. The objective of this study was to elicit stakeholder input on integration of SU/MH
screening using computer-assisted patient-reported outcomes (PROs) into clinical practice.
Methods: We conducted semi-structured interviews with HIV-positive patients who self-reported SU/MH symptoms
on a computer-assisted PROs (n = 19) and HIV primary care providers (n = 11) recruited from an urban academic HIV
clinic. Interviews were audio-recorded and transcribed. We iteratively developed codes and organized key themes
using editing style analysis.
Results: Two themes emerged: (1) Honest Disclosure: Some providers felt PROs might improve SU/MH disclosure;
more were concerned that patients would not respond honestly if their provider saw the results. Patients were also
divided, stating PROs could help overcome stigma but that it could be harder to disclose SU/MH to a computer
versus a live person. (2) Added Value in the Clinical Encounter: Most providers felt PROs would fill a practice gap.
Patients had concerns regarding confidentiality but indicated PROs would help providers take better care of them.
Conclusions: Both patients and providers indicated that PROs are potentially useful clinical tools to improve
detection of SU/MH. However, patients and providers expressed conflicting viewpoints about disclosure of SU/MH
using computerized PROs. Future studies implementing PROs screening interventions must assess concerns over
confidentiality and honest disclosure of SU/MH to understand the effectiveness of PROs as a clinical tool. More
research is also needed on patient-centered integration of the results of PROs in HIV care.
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Background
The HIV treatment continuum includes steps to achieve
and maintain HIV suppression, and reduce HIV trans-
mission. These steps include linkage to and retention in
HIV care through regular HIV clinic visits, antiretroviral
therapy (ART) prescription, ART adherence, and HIV
RNA suppression [1–3]. Optimal engagement in HIV
care allows people living with HIV (PLWH) to benefit
from HIV therapy to improve their own clinical out-
comes and to prevent the transmission of HIV to others
[3]. However, retention in the United States is low, with
over 50% of diagnosed persons failing to establish or
remain engaged in medical care and less than 25% of all
PLWH stably suppressed on ART [3].
Substance use (SU) and mental health (MH) disorders
are highly prevalent among PLWH and are associated
with worse HIV outcomes. The prevalence of SU among
PLWH is high, reported in 10–40% of PLWH [4–7]. The
lifetime prevalence of depression among PLWH has
been reported as high as 45% [8] with recent depressive
symptoms endorsed by 20–50% of PLWH [9–12]. Dual
diagnosis is common; a large prevalence study demon-
strated that 38% of PLWH had both a SU and a mood
disorder [13]. SU and MH disorders among PLWH are as-
sociated with worse adherence to medication, appoint-
ment attendance, and other self-care behaviors [7, 14–16].
Previous studies have revealed an association between
these disorders and worse retention in care [17, 18].
Furthermore, there is inadequate treatment of SU/MH
among PLWH, starting with the under-recognition of
these disorders. Among PLWH with SU disorders, both
discussions with providers regarding SU and receipt of
SU disorder treatment are low [19]. Prior research has
demonstrated that effective SU/MH disorder treat-
ment can improve HIV clinical outcomes [20–23].
However, as in general primary care, depression is
under-recognized [24] and goes untreated or under-
treated in many PLWH [25].
Computer-assisted interviewing may lead to increased
patient disclosure and provider recognition of SU/MH
disorders. Standardized screening using patient reported
outcomes (PROs), defined as reports that come directly
from the patient, rather than typical clinical care or chart
review, increase identification of MH disorders [26]. There
are many potential benefits of computer-assisted
screening to increase patient reporting of SU/MH disor-
ders. Routine use of patient reporting may enhance
patient-provider communication. Furthermore, it may in-
crease provider recognition of these problems and appro-
priate treatment and/or referral. Computer-assisted
screening has been shown to have high acceptability in
HIV clinics [27, 28]. However, potential barriers to clinical
use of these screening measures include clinic space
considerations, increased staff burden, and competing
priorities for both patients and providers. To increase
chances of success, PROs must be integrated into clinic
flow in a patient- and provider-friendly manner, with
high-perceived value of the information to providers [29].
The objective of this qualitative study was to assess
the acceptability of using computer-assisted PROs by
providers and patients in a clinic setting to facilitate
identification and treatment of SU/MH disorders in HIV
primary care. We were interested in learning if the
perception of PROs differed by retention status. Since
people who are not retained are more likely to have SU/
MH issues, we were interested in whether they would be
more or less likely to perceive use of PROs to identify
SU/MH issues as helpful. Our long-term goal with this
work is to determine if the use of computer-assisted
PROs will improve outcomes along the HIV care
continuum by improving engagement in care and
management of SU/MH disorders.
Methods
This study was nested within the Johns Hopkins HIV
Clinical Cohort (JHHCC), an observational study of in-
dividuals receiving HIV care at the Johns Hopkins HIV
Clinic in Baltimore, MD. The cohort has been described
in detail previously [30]. Currently, JHHCC participants
are offered computer-assisted PROs questionnaires every
6 months for research purposes and the results are not
conveyed to the clinical team. These questionnaires
include the Alcohol Use Disorders Identification Test
Alcohol Consumption questions (AUDIT-C), the Alco-
hol, Smoking and Substance Involvement Screening Test
(ASSIST), the Personal Health Questionnaire Depression
Scale (PHQ-8), and the Generalized Anxiety Disorder
(GAD-7) scale. At that time, no other SU/MH screening
was routinely performed in clinic. In addition to those
measures, the PROs include measures of adherence to
HIV therapy, quality of life, etc. (full list in Interview
Guide in Additional file 1).
From January to June 2016, we conducted 11 interviews
with providers and 19 interviews with HIV-positive partic-
ipants (hereafter referred to as patients). Of the 30 inter-
views, 29 were audio-recorded and the other interview (an
individual living with HIV) was documented with field
notes, because the patient declined to be recorded. The
study sample was recruited as follows:
Patient participants
English-speaking adult (≥ 18 years old) patients enrolled
in the JHHCC, who completed a JHHCC PROs assess-
ment from September 2013 through October 2014, and
self-reported drug use, heavy alcohol use, or MH (de-
pression or anxiety) symptoms using clinically relevant
cutoffs from the screening tools were eligible for this
study. This date range of PROs was selected to ensure at
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least 12 months of follow-up data was available to calcu-
late retention measures. Retention status was calculated
using the visit adherence measure (the proportion of
kept visits/ (scheduled visits + kept visits)). Participants
with a visit adherence score of less than 0.80 were
considered not retained in HIV care. Medical record
numbers from this roster of patients were matched with
prior PROs for JHHCC participants who agreed to be
contacted for other research and were subsequently sent
a letter in the mail or approached to participate during a
clinical encounter. We purposively sampled to obtain a
mixture of patients who were retained and not retained
and had SU only, MH symptoms only, or both.
Provider participants
Clinic personnel, including physicians, nurse practi-
tioners and physician assistants, from the Johns Hopkins
HIV clinic were interviewed. Clinical personnel were
sent an email from the principal investigator (PI) to de-
scribe the study and opt-in to participate in the study.
Both provider and patient participants signed informed
consent; patients received $15 for their participation and
providers received $25. This study was approved by the
Institutional Review Board at the Johns Hopkins Univer-
sity School of Medicine.
Study development and design
The semi-structured interview guide was developed
based on our conceptual framework, which incorpo-
rates factors influencing recognition and response to
SU/MH disorders among providers, engagement in
SU/MH care among patients in HIV primary care,
and implementation of PROs as a clinical tool. The
interview guide was iteratively revised as the study
progressed. Patient interviews included questions re-
garding how SU/MH disorders affected retention in
HIV care, prior attempts to access SU/MH treatment
services, and perceived benefits and harms of using
computerized PROs in clinical care, and preferences
regarding receipt of PROs results by their own
medical provider/other members of the clinic team.
Provider interviews included questions regarding
perceived benefits and harms of SU/MH treatment as
related to retention in HIV care, provider/clinic obli-
gation in response to positive screening for SU/MH
disorders, preferences for incorporating computer-assisted
PROs administration into the clinical workflow, delivery
of PROs results. We asked questions regarding additional
domains collected in the PROs, including sexual risk
behavior and adherence to ART, however, this analysis
includes only SU/MH data. (See Additional file 1 for Inter-
view Guides).
Semi-structured in-person interviews were conducted
by a trained research assistant for patient interviews and
by the PI for provider interviews. The PI conducted the
clinical personnel interviews, because the PI is famil-
iar with the clinic flow and procedures needed to
probe and obtain feedback from providers. Interviews
lasted 15–20 min (patients) or 20–45 min (providers).
Interviews were digitally audio-recorded and tran-
scribed verbatim. No personal identifiers were in-
cluded in the transcripts.
Data analysis
Using an application of grounded theory [31], the
research team identified preliminary themes while
reviewing the transcripts, and used an iterative consen-
sus process to continue to refine themes as data analysis
continued. Two separate comprehensive codebooks, (pa-
tients and providers) were developed based on themes.
The team determined clear and applicable code defini-
tions through an iterative consensus process. Two
coders independently coded each transcript and came to
consensus on discrepancies via discussion.
We did not formally calculate inter-coder reliability,
rather we used established methods for addressing
differences in coding due to multiple coders by ad-
dressing all coding discrepancies and reconciling them
through discussion and consensus [32, 33]. We used
QSR NVivo Version 11.0 to apply codes to the tran-
scripts and organize text segments and relevant
quotes abstracted during analysis. Editing style ana-
lysis, by which the coded text is organized to develop
the final themes [34]. We examined whether different
themes were endorsed by individuals who were or
were not retained in HIV care.
Results
Demographics
The demographic characteristics of the patient sample
categorized by retention status are summarized in
Table 1. The racial and gender makeup of the sample
were similar to the Johns Hopkins HIV clinic population,
which is about 75% African American and 34% female.
Overall, 57.9% of the sample was categorized as retained
in HIV care. Twelve patients had active or recent SU, 4
had only MH symptoms, and 3 had both active/recent
SU and MH symptoms. Although the sample size was
small, we observed more non-retained participants with
positive screens for both SU and MH. Additionally, we
observed a higher number of overall positive screens
among non-retained participants.
The majority of the provider sample was female (n = 8,
72.7%). The sample included an array of health profes-
sionals, including 5 physicians (45.5%), 4 nurse practi-
tioners (36.4%), and 2 physician assistants (18.2%).
Overall, there was some ambivalence about whether
the added benefit of the computer-assisted PROs was
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worth the added effort on the part of the patients in
completing the PROs and on the part of providers in
reviewing them. Two themes that emerged were: (1)
Honest Disclosure and (2) Added Value in the Clinical
Encounter. We present these themes with illustrative
quotations below and also provide tables (Tables 2, 3, 4)
with additional quotations.
Qualitative themes
Theme 1: PROs and honest disclosure of SU/MH
Both providers and patients had mixed views about the
PROs to improve detection of SU/MH issues and as a
facilitator of honest SU/MH disclosure. There were op-
posing views on how forthcoming patients would be
when disclosing to a computer compared with disclosing
to a healthcare provider. Some providers and patients
expressed that patients would be less honest if the re-
sults would be conveyed to providers; however, other
stated they would be more honest.
Less willing to honestly disclose SU/MH with PROs
Challenges noted by providers Some providers worried
patients would answer differently if they knew their pro-
vider would see the PROs results versus when the PROs
were completed solely as a research tool. Providers sug-
gested patients would not want to disappoint their pro-
vider, so patients would perhaps be less willing to
disclose SU/MH. Other providers expressed concerns
that patients may be less forthcoming if their PROs re-
sults were documented in their chart:
“I’m very much afraid their answers are going to change
when they know it’s ‘part of their record’” (Physician).
One provider also indicated that the patient-provider
relationship fosters a safe space where patients may feel
more comfortable being honest compared to the com-
puterized PROs setting:
“There are also people who...when they feel they can talk
to their provider do talk to their provider pretty honestly
when they know that they’re going to be able to
speak...in a judgment free zone” (Physician Assistant).
Table 2 PROs and Honest Disclosure of SU/MH – Provider
Viewpoints
Qualitative Theme Exemplar Quotation(s)
Less Willing to Honestly Disclose SU/MH with PROs
Patient does not want provider
to know about stigmatized
behavior
“[It] worries me that they’re
going to change their answers
about substance abuse, alcohol,
and adherence. At least many
of them I think, don’t want to
displease their doctors or don’t
want to share everything with
their doctors in as much detail,
so once you start...telling the
patients you’re telling their
doctors...it might change
answers.” (Physician)
More Willing to Honestly Disclose SU/MH with PROs
More honest with computer “That’s my understanding is that
the data seems to show that if
people can self disclose and it’s
with a computer, they’re more
likely to be honest.” (Physician)
“Because those are like substance
abuse, depression, obviously and
a lot of time, patients won’t tell
you and they would probably
be more frank in answering it
on the system would definitely
help.” (Physician).





African American 11 8
Female 4 4
Age, mean (SD) 51.0 (6.9) 52.6 (4.7)
Age range (33–61) (46–61)
Positive on at least 1 SU screen;
All MH screens negative
7 5
Positive on at least 1 MH screen;
All SU screens negative
3 1
Positive on at least
1 MH and 1 SU screen
1 2
One screen positive (Either SU
or MH)
9 3
Two screens positive (Either SU
or MH)
1 4
Three screens positive (Either SU
or MH)
1 1
Table 3 PROs and Honest Disclosure of SU/MH – Patient
Viewpoints
Qualitative Theme Exemplar Quotation(s)
Less Willing to Honestly Disclose SU/MH with PROs
Harder to disclose
to computer
“It takes a lot for a person to express how they
feel when you can be face to face with
somebody. Emotionally and physically...being
face to face with her ... It’s easier.” (Patient 20,
Not Retained, MH only)
Fear of Provider
Judgement
“Other patients see [will start] missing their
appointments because they ashamed of what
the doctor seen. Especially when you bring it to
their attention...They’ll start shying away from
the clinic” (Patient, Retained, SU only).
More Willing to Honestly Disclose SU/MH with PROs
Easier to disclose
to computer
“That would give the doctor herself an extra
little something that well, I can read this and
maybe they don’t want to open to me, but
they’ll open up to this. So I think that’d be real
good.” (Patient 19, Retained, SU only)
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Challenges noted by patients Like the providers, a few
patients expressed hesitation to disclose honest results
due to fear of being judged both in context of PROs and
standard clinical encounters. One patient expressed that
this fear of judgment might even drive people away from
clinic and have a negative effect on the provider-patient
relationship. Interestingly, none of the not retained
patients expressed fear of provider judgment as a potential
barrier to disclosing SU/MH problems. One patient de-
scribed this fear of judgment in the following way:
“A lot of times a lot of people [are] afraid to discuss it
because then they may… then they thinking that now
the doctor may have a different conception of me or
view of me and start treating me differently” (Patient,
Retained, MH only).
Table 4 Added Value in the Clinical Encounter – Provider Viewpoints
Qualitative Theme Exemplar Quotation(s)
Challenges of PROs in the Clinical Encounter
Difficult to prioritize “What would be the hierarchy in what do we choose to address during this particular
patient encounter versus what would we delay ... what is your obligation, then, to address
everything, which I think is kind of a bigger issue if these are sort of fed back, do you have
to address everything?” (Physician)
Detracts from patient-centeredness “If I never ask those questions [referring to SU/MH questions] ...that would take away from
that development of a [patient-provider] relationship, knowing who they are as a person
and what it is that they’re dealing with.” (Physician)
“I will only work in a room where I can share a screen with the patient so I want them to
see what I’m seeing ...And I’m not sure how some are going to react [to PRO results]. I’m
worried it could actually hurt the doctor patient relationship. One… [providers] may think
they don’t have to ask because it’s been asked. Two, patients are going to see. Three, I’m
checking boxes again.” (Physician)
Have information but patient may not be
ready to do anything about it
“There is a potential I guess I think of it as little bit of analogous to a testing you know too
sensitive in a way, which is that we’re going to screen more, we are going to find more.
May or may not mean that the patients wanna do something about it.” (Physician Assistant)
Advantages of PROs in the Clinical Encounter
Compelled to act “I think we would all feel compelled to that oh, now I’ve seen this, I really need to do
something about this.” (Physician)
Knowing severity helps set visit priorities “I see severe I’m thinking, you know, we really need to spend a lot of time on this and if
it’s moderate, I would give them a referral, but I think I might make different clinical
positions depending on if I actually had an official screen for severity.” (Physician)
Springboard for discussion with patient “You know, it’s kind of on the table and I can say you know, I’ve looked over your response
forms and I’ve noticed these things, you know, what do you think? It looks like things are
going well here, but maybe not here. You’ve talked...you haven’t told me about this recent
drug use.” (Nurse Practitioner)
“Look, we’ve gone through all of this stuff, you may or may not have talked to your doctor
about it… Are there any of these you want to talk to your doctor about? Because then, it’s
patient driven, it’s patient centered” (Physician).
“And it just opens up the opportunity to again, talk about the availability of resources
within the clinic to help better address that.” (Nurse Practitioner).
Improves efficiency “It answers questions for me that I than frankly don’t have to initially ask.” (Physician)
Fills gap in practice “So when I think standardization of questions that can summarize things for you in a very
busy clinic where you have 30 min to get the evaluation done ...if it were done
systematically at X intervals, for example, it would be very useful ... I see it as an opportunity
to enhance my assessment of the patient and if ...there was something that was detected,
then I could be more aggressive in approaching it” (Nurse Practitioner)
May capture issues that were previously
undetected
“I think if you can actually pick up undiagnosed depression or undiagnosed anxiety and
get someone into treatment for that, there’s actually a real value to actually having this
screening and then being able to make the appropriate referral.” (Physician)
“I think these questions are designed to try and tease out the people who are being over
or under expressive on that [referring to the depression and anxiety standardized
questionnaires]...I think sometimes those are harder questions as a clinician to ask”
(Nurse Practitioner).
“Having some other process...so picking up new problems, that’s very helpful, but when it’s
an existing problem...You know I’m worried less about the extreme, which I think we pick
up pretty well, but I think...it’s those in the middle where you know, they’re not clinically
depressed, but they’re also not quite where they should be” (Physician).
Standardized questions “I think it gives a more structured and quantitative way of looking at what people and what
they are experiencing, so in that sense, I think it would be helpful.” (Physician)
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Other patients suggested SU/MH disclosure would
cause their provider to be disappointed. Social desirabil-
ity could impede honest disclosure:
“Certain things I wouldn’t disclose, because… I’ll feel
bad to tell her that I’m drinking and missed my
medication” (Patient, Retained, SU only).
More willing to honestly disclose SU/MH with PROs
Advantages noted by providers In contrast to the
aforementioned viewpoints, some providers felt that
the PROs as a clinical tool would improve patients’
ability to honestly disclose SU/MH. This would be
beneficial to providers, because improved detection
could lead to improved management. Rather than
expressing concern about decreasing honest disclosure
due to social desirability, providers expressed that the
PROs would mitigate these fears, leading to more
forthcoming disclosure:
“There is a tendency for patients to down play the
things that are really stigmatized with your
provider...I don’t think that I get really good
substance use history and understand what’s going
on until, and this is an exaggeration, but until they
are at the point where they really want to stop”
(Physician Assistant).
Many providers cited the literature indicating patients
were more likely to disclose sensitive information to a
computer than in a face-to-face clinical encounter. One
provider expressed that the PROs would increase hon-
esty, because the process would give patients the space
and time to formulate truthful answers:
“People sometimes don’t recognize what they’re
thinking until maybe they’re having a quiet moment
to read questions and think about their
[answer]...maybe the written or the readable word
helps people be a little more honest”
(Nurse Practitioner).
Advantages noted by patients Like providers, patients
felt the PROs would be beneficial, because it would
provide a tool to help patient alert providers to issues
that patients are unlikely to disclose during their
appointment:
“But if you see it on black and white… they [patients]
won’t tell you, but they’ll put it on paper…
[Interviewer asks why patient thinks this is] Shame.
Shame. Shame” (Patient, Retained, SU only).
Some patients indicated that provider recognition of
honest disclosure on the PROs would foster improved
rapport between patients and providers. This patient
expressed his provider would appreciate forthcoming
answers on the PROs results:
“I think it would be about appreciation of honesty
from the patient if my doctor was to read something
and say oh wow. He was really honest about
everything” (Patient, Retained, SU only).
Theme 2: Added value in the clinical encounter
As noted by many clinicians, the busy clinical setting, with
full schedules and a short time allotted for appointments,
sometimes left providers stressed and unable to suffi-
ciently and consistently assess for SU/MH problems. This
was compounded by the varying needs that are a patient’s
priority for the visit. Some providers felt the PROs would
detract from patient-centered care, because it would be
something else in the visit that needed to be addressed.
Several providers felt they would have a difficult time pri-
oritizing, planning, and carrying out a response personal-
ized to each patient’s needs and that the additional
information from the PROs might make that harder. Con-
versely, many providers expressed that the PROs results
would alleviate the burden of screening for SU/MH. The
PROs were seen as a detailed and structured assessment
to alert and guide the provider to address the issue. Pa-
tients did not express concern about the potentially
overwhelming volume of information the PROs would
provide but did think the PROs would improve the care
from their HIV provider, including SU/MH treatment.
Challenges noted by providers Generally, providers
were concerned that viewing all PROs results would take
too much time to process and evaluate to effectively in-
corporate and prioritize for a clinic encounter. This
overwhelming volume of information could potentially
consume the clinical encounter. As one provider noted:
“The only downside I see is ...that we might not be able
to address anything or everything or necessarily know
how to address everything” (Physician).
Providers generally endorsed wanting a score for the
assessment along with an interpretation and recommen-
dation for the results. Some providers suggested incorp-
orating the assessment results into the EMR; however,
they worried that including the information in the EMR
would add time without improving the patient-provider
relationship or medical care. A minority of providers
feared this technological-based intervention had the
potential to decrease patient centeredness:
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“I’m worried that we spend less time doing what we
should be doing, which is talking with our patients,
examining them, explaining things, hearing
their input, as opposed to looking through yet
another series of things that I have to go
through”(Physician).
Another concern that was expressed by a minority
of providers was that the SU and MH history taking
in the patient interview is an integral part of building
the patient-provider relationship, and that providers
themselves should ask SU/MH questions rather than
having this part of the history conducted by a com-
puterized PRO.
Challenges noted by patients A minority of patients
expressed that the PROs would not be valuable to them
personally as a clinical tool, because they already dis-
closed all issues to their provider and would not change
the patient-provider relationship or the interaction at
medical visits. These were patients with a strong rela-
tionship with their provider:
“I don’t keep nothing from my doctor...I really don’t.
You know, you keep stuff from your doctor, they can’t
treat you” (Patient, Retained, SU only).
One patient who described a close patient-provider
relationship subsequently noted that other patients
might not be as forthcoming with their doctor; it is
unclear, however, if they felt that this problem will be
ameliorated with the PROs approach.
Patients expressed concern about who would view
their PROs results, stating that they would need to get
to know the provider before they would be comfortable
having their results disclosed. Some patients also de-
scribed the lack of control over who could view the
PROs results once transmitted to the medical chart. As
the following patient said:
“I don’t want everybody to know my business and like
I said… for it to be confidential” (Patient, Not
Retained, SU only).
Although patients did not explicitly state that they
would complete PROs differently, talking about SU/MH
evoked concerns about confidentiality and trust, whether
through verbally reporting problems or on the PRO. Pa-
tients described needing a foundation of trust in order
to disclose issues:
“For me to tell you about my private life and what’s
going on with it, I have to like you and trust you”
(Patient, Not Retained, SU only).
Advantages noted by providers While recognizing that
PROs results might affect clinic flow, other providers
were less concerned about the time to review the results
and expressed that the PROs would both fill a gap in the
provider’s practice by improving the assessment and
detection of SU/ MH disorders and save time. For
example, one provider expressed how the PROs would
detect SU/MH problems that the provider is currently
unable to consistently and thoroughly assess:
“A lot of time in the visit, you just get backed up with
whatever the patient brings in for the visit like that
you don’t really get to ask all those questions”
(Physician).
The detailed and standardized PROs results were seen
as beneficial to provider practices by improving detec-
tion of SU/MH disorders, as the following provider
expressed about the depression-screening questionnaire:
“I do not screen, I don’t ask these eight or ten
questions... I believe, and it’s all it is a subjective belief,
I believe I’m pretty good at picking up on it, but I have
no proof” (Physician Assistant).
Additionally, several providers stated that knowing the
severity of a patient’s issue based on the PROs results
could help them prioritize what to address at the visit.
Two providers presented implementation strategies to
ensure the PROs can be used to supplement and support
the HIV primary care visit rather than detract from
patient-centered care. One physician suggested:
“What if the patient does the PROs and they get the
feedback, gosh, you have high scores on depression,
drug use, and low physical activity, which of these
would you like to talk to your doctor about today?”
(Physician).
A few providers indicated the PROs results could be
seen like a lab value, to which prompt evaluative action
on the part of the provider:
“The same way if you have a CT scan with an
abnormal cancer and we get this information. This is
important. This could be a barrier to patient’s
treatment” (Physician).
Finally, in the discussion of the PROs at the study site,
where they are already in use in a research capacity, one
provider expressed the importance of research results
that provide important information for clinical diagnoses
and management and expressed frustration at not re-
ceiving the results:
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“You guys do get this information every six months
whether I get it or not. What do you guys do with it?
[Response from interviewer: It goes into the research
database]. That’s the same thing those research people
do. They get stuff and they don’t tell you anything”
(Physician).
Advantages noted by patients Patients expressed the
PROs could improve the patient-provider relationship by
increasing the “bond” with providers. Patients felt the
PROs would improve the care they received, because the
results would be valuable for treatment management:
“They would go the…extra mile to help me more, to try
to take another step … See, see I’m getting better, get off
the drugs and stuff” (Patient, Not Retained, SU only).
Because of the perceived value for improving care, a
patient was frustrated that research results were not
used to improve care and stated:
“Even though we take them kind of surveys and they
ask you them kind of questions. I still don’t see
nowhere where they trying to assist someone who do
have a problem…So why asking me? When you asking
them questions, you just really being nosy because
...nothing been implemented to help people that is
using that really may want to get off using” (Patient
18, Retained, MH only).
This quotation suggests that some patients complete
surveys with the hope that the responses will trigger
support, even if they have been told it is only for
research.
Discussion
In a qualitative study of providers and PLWH from an
urban academic HIV clinic, stakeholders expressed opti-
mism about the potential for computer-assisted PROs to
enhance identification of SU/MH disorders. The main
themes identified about the use of computerized PROs
in clinical care were: 1) Honest Disclosure and 2) Added
Value in the Clinical Encounter. Patients and providers
had mixed views about the impact the computer-assisted
PROs would have on honest disclosure. One potential
benefit was increased honesty when interfacing with a
computer-delivered questionnaire, as there would be less
social desirability bias as compared to a provider inter-
view [35, 36]. However, the opposing view was that the
strength of the patient-provider relationship ultimately
determines whether patients disclose SU/MH issues to
their providers and that the computer-assisted PROs
might actually decrease patient-centeredness and
rapport building. Some providers expressed concern re-
garding impeding clinic flow due to PROs, with others
stating that having the results of SU/MH assessments
could actually expedite care. Prior work has shown that
screening for substance use [37] and mental health [38]
in a primary care setting is acceptable to patients. How-
ever, time was cited as a barrier to implementing screen-
ing and brief intervention [39], which was raised by
some providers. Patients were not certain that PROs
would augment the clinic visit if their provider “already
knows everything” about them.
The ultimate impact of computer-assisted PROs on
retention in HIV care is unclear. Prior to starting the in-
terviews, we thought there might be different views of
PROs expressed by retained and not retained patients
(e.g., non-retained patients might express more concerns
about confidentiality or limited usefulness of the PROs).
However, patients’ views on PROs did not vary substan-
tially by retention status. This suggests that PROs com-
pletion itself is likely not a barrier to retention, but
beyond that conclusion, it is difficult to predict the effect
of PROs on retention without additional research. What
became clear during the study was that the integra-
tion of PROs must reinforce patient-centeredness and
strong patient-provider relationships. This will foster
an environment where the important work to ensure
adequate follow up of a newly identified SU/MH dis-
order can occur.
There is long-standing interest in using PROs to improve
detection of clinical issues, improve patient-provider com-
munication, and monitor response to treatment [40], how-
ever, there is still little empiric data supporting the clinical
utility of PROs [41]. The results of a qualitative study of
providers in HIV clinic sites that have integrated PROs into
clinical care [42] differed from ours in that those providers
did not report concern that the patients might fail to dis-
close behavior on the PROs. At those clinics, the results are
viewed by the provider but not entered into the patients’
medical records. Similar to our results, the authors noted
that providers who had confidence in the strength of their
relationship with the patient were less likely to find the
PROs helpful. It has been previously shown that
self-administration (compared with face-to-face interview)
may increase the disclosure of stigmatized conditions or
behaviors [43, 44]. However, providers still may not trust
that patients are truthfully disclosing [45]. From the patient
side, at least one patient highlighted the need for a robust
rapport between patient and provider to improve detection
and management of SU/MH issues. Without this founda-
tion patients may be unwilling to disclose such issues in the
clinic setting. Additional findings pertinent to our future
work were that providers wanted patients to identify an
issue that was pressing to them, rather than simply receiv-
ing results of all screens. Finally, providers wanted more
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training on managing the results of positive screens. Our
work adds to the published literature by eliciting view-
points from both patients and providers and starting to
examine the impact of PROs on retention in HIV care.
The limitations of our study are that we had data from
one clinic, and we were recruiting individuals who had
already agreed to participate in the PROs administered
through the parent cohort study; we did not have infor-
mation from people who refused the PROs even as re-
search tool. The SU/MH symptom data and subsequent
retention data was collected in advance of the interview
for this study and may not have accurately reflected
current behavior of the PLWH in care. Finally, we did not
recruit anyone who was completely disengaged from care,
i.e., not attending HIV clinic, therefore our responses may
not accurately reflect their concerns and viewpoints. A po-
tential limitation of the provider interviews, given that
they were conducted by the Principal Investigator, was
that colleagues who knew the Principal Investigator’s line
of research might not have been as forthcoming about
negative perceptions about the use of PROs.
Conclusions
With this work, we gathered stakeholder input regarding
logistical challenges of implementing SU/MH screening in
a busy clinic as well as the perceived utility of screening.
Additionally, we heard from patients about their experi-
ences disclosing SU/MH in their HIV primary care ap-
pointments. Patients believed that disclosure can help the
patient-provider relationship and the quality of care re-
ceived, but only if it is done in the context of confidential-
ity and trust. Thus, how the information about SU/MH is
obtained may not matter as much to the patients as the
ensuing conversation, which should be empathetic, sup-
portive, and productive. Our next steps with this work are
to pilot an intervention in which patients completing the
PROs can select one result they would like to address with
their provider, enhancing the patient-centeredness of the
screening. Simultaneously, we will work to ensure that
there are resources in place to help providers have sup-
portive conversations and make appropriate treatment de-
cisions and/or referral plans. We will emphasize the
development of sustainable systems that do not exces-
sively increase provider burden to have the largest poten-
tial impact on retention in HIV care.
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